SCHULMAN AMY W — SEC Form 4 filings
SEC reporting owner CIK 1438226. 16 Form 4 filings on record with FilingPulse; latest filed 2026-05-22.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-02-05 to 2026-05-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 4 filings — 3,133,919 shares, $22,009,943 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 30,226 shares, $5,272,021 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
- Largest priced transaction: purchase of 909,090 shares @ $11.00 ($9,999,990) in Camp4 Therapeutics Corp, filed 2024-10-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Camp4 Therapeutics Corp (CAMP) | 10% owner | 3 | 4 legs · 3,125,369 sh · $21,999,979 | — | 16 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Director | 7 | — | 4 legs · 30,200 sh · $5,264,546 | 13 |
| FRACTYL HEALTH, INC. (GUTS) | Director | 3 | 1 leg · 8,550 sh · $9,964 | — | 2 |
| Elevance Health, Inc. (ELV) | Director | 3 | — | 1 leg · 26 sh · $7,475 | 2 |
Form 4 filings — SCHULMAN AMY W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-22 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/award (A): 838 @ $0 · Grant/award (A): 1,802 (derivative) @ $0 | EDGAR |
| 2026-05-15 | 4 | Elevance Health, Inc. (ELV) | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-14 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Option exercise (M): 11,250 @ $70.20 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
| 2026-03-23 | 4 | Elevance Health, Inc. (ELV) | Sale (S): 26 @ $287.50 | EDGAR |
| 2026-02-03 | 4 | Elevance Health, Inc. (ELV) | Grant/award (A): 218 @ $0 | EDGAR |
| 2025-09-11 | 4 | Camp4 Therapeutics Corp (CAMP) jointly with Polaris Management Co. VII, L.L.C., Polaris Partners VII, L.P., Polaris Entrepreneurs' Fund VII, L.P., Polaris Partners X, L.P., Polaris Partners GP X, L.L.C., Chee Brian | Purchase (P): 1,221,721 @ $1.53 · Purchase (P): 85,468 @ $1.53 | EDGAR |
| 2025-06-13 | 4 | FRACTYL HEALTH, INC. (GUTS) | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2025-05-12 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/award (A): 775 @ $0 · Grant/award (A): 1,558 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | FRACTYL HEALTH, INC. (GUTS) | Purchase (P): 8,550 @ $1.17 | EDGAR |
| 2025-03-14 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Option exercise (M): 2,750 @ $131.21 · Option exercise (M): 2,750 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4/A | Camp4 Therapeutics Corp (CAMP) jointly with Polaris Management Co. VII, L.L.C., Polaris Partners VII, L.P., Polaris Entrepreneurs' Fund VII, L.P., Polaris Partners X, L.P., Polaris Partners GP X, L.L.C., Chee Brian | Conversion (C): 1,250,061 · Conversion (C): 87,448 · Conversion (C): 353,718 · Conversion (C): 24,745 · Purchase (P): 909,090 @ $11 · Conversion (C): 14,020,475 (derivative) · +3 more | EDGAR |
| 2024-10-15 | 4 | Camp4 Therapeutics Corp (CAMP) jointly with Polaris Management Co. VII, L.L.C., Polaris Partners VII, L.P., Polaris Entrepreneurs' Fund VII, L.P., Polaris Partners X, L.P., Polaris Partners GP X, L.L.C. | Conversion (C): 1,250,061 · Conversion (C): 87,448 · Conversion (C): 353,718 · Conversion (C): 24,745 · Purchase (P): 909,090 @ $11 · Conversion (C): 14,020,475 (derivative) · +3 more | EDGAR |
| 2024-06-27 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Option exercise (M): 8,500 @ $131.21 · Sale (S): 8,500 @ $240 · Option exercise (M): 8,500 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Option exercise (M): 30,000 @ $66.83 · Sale (S): 10,121 @ $148.21 · Sale (S): 11,516 @ $148.93 · Sale (S): 63 @ $149.76 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-20 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/award (A): 5,228 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Fractyl Health, Inc. (GUTS) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1438226 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →